NCT05076370View on ClinicalTrials.gov

Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Addiction
Interventions
DRUG

CBD Day 1

CBD 400mg

DRUG

CBD Day 2

CBD 800mg

DRUG

CBD Day 3

CBD 1200mg

Trial Locations (1)

06516

Veteran Affairs Hospital, West Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER